These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5791435)

  • 1. Stability of heparin S35 attached to a modified polyurethane vascular prosthetic.
    Gardner DL; Sharp WV; Ewing KL; Finelli AF
    Trans Am Soc Artif Intern Organs; 1969; 15():7-14. PubMed ID: 5791435
    [No Abstract]   [Full Text] [Related]  

  • 2. Nonthrombogenic materials via a simple coating process.
    Grode GA; Anderson SJ; Grotta HM; Falb RD
    Trans Am Soc Artif Intern Organs; 1969; 15():1-6. PubMed ID: 5791389
    [No Abstract]   [Full Text] [Related]  

  • 3. Electrolour: achievement of long term vascular tolerance.
    Sharp WV; McVay WP; Flaksman RJ; Wright J
    Surg Forum; 1969; 20():141-2. PubMed ID: 5383030
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced thrombogenic characteristics of expanded polytetrafluoroethylene and polyurethane arterial grafts after heparin bonding.
    Esquivel CO; Björck CG; Bergentz SE; Bergqvist D; Larsson R; Carson SN; Dougan P; Nilsson B
    Surgery; 1984 Jan; 95(1):102-7. PubMed ID: 6691173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrolour: a new vascular interface.
    Sharp WV; Gardner DL; Andresen GJ; Wright J
    Trans Am Soc Artif Intern Organs; 1968; 14():73-7. PubMed ID: 5701577
    [No Abstract]   [Full Text] [Related]  

  • 6. The urokinase-heparin bonded synthetic surface. An approach to the creation of a prosthetic surface possessing composite antithrombogenic and thrombolytic properties.
    Kusserow BK; Larrow R; Nichols J
    Trans Am Soc Artif Intern Organs; 1971; 17():1-5. PubMed ID: 5158091
    [No Abstract]   [Full Text] [Related]  

  • 7. [Test of carotid artery replacement by polyurethane artificial vascular graft with recombinant fibrinolytic enzyme factor II-modified lumina in dogs].
    Pan S; Yin S; Yao J; Zheng H; Yi W; Dai G
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jul; 22(7):832-7. PubMed ID: 18681285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparin sorptivity and blood compatibility of carbon surfaces.
    Bokros JC; Gott VL; LaGrange LD; Fadali AM; Ramos MD
    J Biomed Mater Res; 1970 Jun; 4(2):145-87. PubMed ID: 5460574
    [No Abstract]   [Full Text] [Related]  

  • 9. Improvement of patency rate in heparin-coated small synthetic vascular grafts.
    Walpoth BH; Rogulenko R; Tikhvinskaia E; Gogolewski S; Schaffner T; Hess OM; Althaus U
    Circulation; 1998 Nov; 98(19 Suppl):II319-23; discussion II324. PubMed ID: 9852921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The thrombogenic characteristics of small caliber polyurethane vascular prostheses after heparin bonding.
    vd Lei B; Bartels HL; Dijk F; Wildevuur CR
    Trans Am Soc Artif Intern Organs; 1985; 31():107-10. PubMed ID: 3939271
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombogenic surfaces, classification and in vivo evaluation.
    Gott VL; Furuse A
    Fed Proc; 1971; 30(5):1679-87. PubMed ID: 5119372
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of polyurethane valve cusp calcification with covalently attached bisphosphonate diethylamino moieties.
    Alferiev I; Stachelek SJ; Lu Z; Fu AL; Sellaro TL; Connolly JM; Bianco RW; Sacks MS; Levy RJ
    J Biomed Mater Res A; 2003 Aug; 66(2):385-95. PubMed ID: 12889009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyurethane arterial prosthesis: experimental evaluation.
    Martin-Mondiere C; David P; Loisance D
    Ann Vasc Surg; 1990 Jan; 4(1):52-7. PubMed ID: 2297475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel polyaminoetherurethaneureas and development of antithrombogenic material by their chemical modifications.
    Shibuta R; Tanaka M; Sisido M; Imanishi Y
    J Biomed Mater Res; 1986 Sep; 20(7):971-87. PubMed ID: 3760013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new plastic interface which has antithrombotic characteristics and appears to mimic the vascular interface.
    Sawyer PN; Kaplitt M; Afshar A; Miller M; Postal RH
    Trans Am Soc Artif Intern Organs; 1966; 12():183-7. PubMed ID: 5960699
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of a new antithrombogenic polyurethane-polysiloxane complex biomaterial.
    Ohkubo N; Hirose H; Matsuda H; Nakano S; Shirakura R; Maeda S; Ohtani M; Yoda R; Kawashima Y
    ASAIO Trans; 1986; 32(1):193-7. PubMed ID: 3778711
    [No Abstract]   [Full Text] [Related]  

  • 17. Surface chemical evaluation of thromboresistant materials before and after venous implanttion.
    Baier RE; Gott VL; Feruse A
    Trans Am Soc Artif Intern Organs; 1970; 16():50-7. PubMed ID: 5454207
    [No Abstract]   [Full Text] [Related]  

  • 18. [Small-caliber arterial prostheses: influence of porosity].
    Ratto GB; Motta G
    J Chir (Paris); 1983 May; 120(5):337-42. PubMed ID: 6223934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of a new photoreactive derivative of dipyridamole and its use in the manufacture of artificial surfaces with low thrombogenicity.
    Aldenhoff YB; Pijpers AP; Koole LH
    Bioconjug Chem; 1997; 8(3):296-303. PubMed ID: 9177834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of intravascular thrombosis by an artificial myocardial tunnel.
    Carlson RG; Edlich RF; Landé AJ; Lillehei RC; Lillehei CW
    J Thorac Cardiovasc Surg; 1969 Oct; 58(4):614-6. PubMed ID: 5344199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.